Enter your search into one or more of the boxes below:
You can refine your search by selecting from any of the options below:
Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries
Foyalty 285

Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries (Hardback)

To Order. Estimated despatch in 1-3 weeks.
Email me when back in stock


This up-to-date book examines pharmaceutical development, access to medicines, and the protection of public health in the context of two fundamental changes that the global political economy has undergone since the 1970s, the globalization of trade and production and the increased harmonization of national regulations on intellectual property rights.

With authors from eleven different countries presenting case studies of national experiences in Africa, Asia and the Americas, the book analyzes national strategies to promote pharmaceutical innovation, while at the same time assuring widespread access to medicines through generic pharmaceutical production and generic pharmaceutical importation. The expert chapters focus on patents as well as an array of regulatory instruments, including pricing and drug registration policies.

Presenting in-depth analysis and original empirical research, this book will strongly appeal to academics and students of intellectual property, international health, international political economy, international development and law.

BusinessEconomicsDevelopment economicsLawLaws of Specific jurisdictionsIntellectual property lawLawLaws of Specific jurisdictionsSocial lawMedical & healthcare lawMedical & VeterinaryMedicine: general issuesPublic health & preventive medicine Publisher: Edward Elgar Publishing Ltd Publication Date: 30/11/2011 ISBN-13: 9781849800143  Details: Type: Hardback Format: Books
Availability: To Order. Estimated despatch in 1-3 weeks.  

Edited by Kenneth C. Shadlen, London School of Economics and Political Science, UK, Samira Guennif, Universite Paris 13, France, Alenka Guzman, Autonomous Metropolitan University-Iztapalapa, Mexico and Narayanan Lalitha, Gujarat Institute of Development Research, India

More books by Kenneth C. Shadlen

More books by Samira Guennif

More books by Alenka Guzman

More books by Narayanan Lalitha

Customer Reviews

INTELLECTUAL PROPERTY RIGHTS MEET PUBLIC HEALTH WORLDWIDE An appreciation by Phillip Taylor MBE and Elizabeth Taylor of Richmond Green Chambers Published by Edward Elgar, this book will appeal strongly to a wide range of professionals, academics and students with interest in and involvement in public health issues worldwide, specifically the pharmaceutical industry. As the subtitle indicates, the focus here pertains to access to drugs in developing countries, an issue which has raised its profile in the public consciousness with increasing frequency, especially of late. To cite just one example, the book’s four expert editors point out that post-Apartheid governments in South Africa have struggled with meeting the dual objectives of increasing local production of essential medicines, whilst reducing prices. Bearing all this in mind -- including the ongoing controversies centering on branded versus generic pharmaceutical products -- the pharmaceutical industry, which is concentrated mainly in only six countries, relies very much on patents and trademarks and is therefore heavily dependent on intellectual property rights, patents in particular. One assertion made by the editors, however -- all of whom hail from top universities worldwide, including the LSE and McGill -- is that the ongoing harmonization of IP rights globally over the last three or four decades, has meant that the pharmaceutical industry generally, has increased its presence in developing countries, both with respect to production and distribution. The 13 international contributors to this study – including the four editors – examine all pertinent aspects of this fascinating field, including the latest developments across at least eleven different countries. Case studies are presented of national experiences in Africa, Asia and the Americas, notably Canada. Pricing and drug registration policies, as well as patents and other regulatory instruments are systematically and methodically examined. Interestingly, the book is the ultimate result of a collaborative project entitled ‘Globalisation and Public Health in Developing Countries’ funded by the Foundation Maison des Sciences de l’Homme in Paris. For those involved in healthcare disciplines – and that includes lawyers with pharmaceutical clients – the book is timely, topical, and packed with carefully researched information which puts a number of major issues relating to pharmaceuticals in perspective. Of great value to researchers are the copious footnotes and extensive bibliographies which follow most of the articles. If you’re a student, academic, or practitioner in related IP issues, particularly international health, international political economy, or international development and law, this book certainly provides you with an impressive mine of information if you find yourself having to argue your corner on any number of legal, economic and ethical issues in this complex field of study.

- 10/04/2012
Report this Review
Leave Review


Delivery Options

All delivery times quoted are the average, and cannot be guaranteed. These should be added to the availability message time, to determine when the goods will arrive. During checkout we will give you a cumulative estimated date for delivery.

Location 1st Book Each additional book Average Delivery Time
UK Standard Delivery FREE FREE 3-5 Days
UK First Class £4.50 £1.00 1-2 Days
UK Courier £7.00 £1.00 1-2 Days
Western Europe** Courier £17.00 £3.00 2-3 Days
Western Europe** Airmail £5.00 £1.50 4-14 Days
USA / Canada Courier £20.00 £3.00 2-4 Days
USA / Canada Airmail £7.00 £3.00 4-14 Days
Rest of World Courier £22.50 £3.00 3-6 Days
Rest of World Airmail £8.00 £3.00 7-21 Days

** Includes Austria, Belgium, Denmark, France, Germany, Greece, Iceland, Irish Republic, Italy, Luxembourg, Netherlands, Portugal, Spain, Sweden and Switzerland.

Delivery Help & FAQs

Returns Information

If you are not completely satisfied with your purchase*, you may return it to us in its original condition with in 30 days of receiving your delivery or collection notification email for a refund. Except for damaged items or delivery issues the cost of return postage is borne by the buyer. Your statutory rights are not affected.

* For Exclusions and terms on damaged or delivery issues see Returns Help & FAQs

You might also like

Law, Palliative Care and Dying: Legal...
John Lombard
How to Change Your Mind: The New...
Michael Pollan
Excellence Beyond Compliance:...
William White
ISO 13485:2016: A Complete Guide to...
Itay Abuhav
© W&G Foyle Ltd
Foyles uses cookies to help ensure your experience on our site is the best possible. Click here if you’d like to find out more about the types of cookies we use.
Accept and Close